See All Slides - tctmd.com

Slides

Presentation TCT 2014

ENGAGER - Technology Review, Clinical Results, and Case Examples

Presenter: Hendrik Treede

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: New Insights From INPACT SFA II

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, John R. Laird Jr

September 15, 2014

Presentation TCT 2014

Case #1: Spontaneous Dissection

Presenter: Hector M. Garcia-Garcia, John McB. Hodgson, Robert J. Russo, Ning Guo

September 15, 2014

Presentation TCT 2014

Pro Bioabsorbable Polymer-Based Metallic DES!

Presenter: Robert A. Byrne

September 15, 2014

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Cangrelor II: New Data from the FDA Advisory Board Panel

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux, Robert A. Harrington

September 15, 2014

Presentation TCT 2014

Clinician Perspective

Presenter: James A. Goldstein

September 15, 2014

Presentation TCT 2014

Basic Bifurcation Guidance: When to Start with a Provisional 2-Stent Technique (with Case Examples)

Presenter: Yves R. Louvard, Bernhard Reimers, Elvin Kedhi, Thierry Lefevre

September 15, 2014

Presentation TCT 2014

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Presenter: Matthew G. Hillebrenner, Martin B. Leon, Aaron V. Kaplan, William H. Maisel

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Advertisement

Slides

ENGAGER - Technology Review, Clinical Results, and Case Examples

Randomized Controlled Trials I: New Insights From INPACT SFA II

Case #1: Spontaneous Dissection

Pro Bioabsorbable Polymer-Based Metallic DES!

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Cangrelor II: New Data from the FDA Advisory Board Panel

Clinician Perspective

Basic Bifurcation Guidance: When to Start with a Provisional 2-Stent Technique (with Case Examples)

Keynote Lecture I: The New FDA-CDRH: Lessons Learned, Current Challenges, and Future Vision

Enhanced Effects of Primed Peripheral Monocytes

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content